Minntech investigating Biocor oxygenator blood pressure drops; firm advises customers to suspend use.
This article was originally published in The Gray Sheet
MINNTECH INVESTIGATION INTO BIOCOR OXYGENATOR BLOOD PRESSURE DROPS should shed light on the cause of the problem within three to four weeks, the firm states. Minntech sent a letter to its international distributors for the device on June 27 asking them to tell customers to stop using the oxygenator due to "reports of unexplained high pressure drops" during cardiopulmonary bypass procedures. The company is drafting another letter to perfusionists that it expects to send early in the week of July 1.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.